0

    543616

    TLL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Trident Lifeline Limited Share Price Today

    Investment Returns

    Over 1 Month 5.86% Over 3 Months 4.56% Over 6 Months -14.94% Over 1 Year -3.37%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Trident Lifeline Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 310.00
    • P/E Ratio (TTM) 17.21
    • Beta -0.26
    • Book Value / share 83.03
    • Return on equity 22.04%
    • EPS (TTM) 15.16
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 6.01
    info icon alternate text

    Trident Lifeline Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 31.97
    Operating Expense 0.00
    Net Profit 6.01
    Net Profit Margin (%) 18.79
    Earnings Per Share (EPS) 5.04
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 23.67
    Operating Expense 18.64
    Net Profit 4.01
    Net Profit Margin (%) 16.94
    Earnings Per Share (EPS) 3.47
    EBITDA 7.17
    Effective Tax Rate (%) 32.26
    Particulars SEP 2025 (Values in Cr)
    Revenue 27.44
    Operating Expense 22.07
    Net Profit 4.94
    Net Profit Margin (%) 18.00
    Earnings Per Share (EPS) 4.26
    EBITDA 7.49
    Effective Tax Rate (%) 23.76
    Particulars JUN 2025 (Values in Cr)
    Revenue 18.82
    Operating Expense 14.73
    Net Profit 3.48
    Net Profit Margin (%) 18.49
    Earnings Per Share (EPS) 3.02
    EBITDA 5.47
    Effective Tax Rate (%) 24.83
    Particulars MAR 2025 (Values in Cr)
    Revenue 20.85
    Operating Expense 16.45
    Net Profit 4.35
    Net Profit Margin (%) 20.86
    Earnings Per Share (EPS) 3.79
    EBITDA 7.18
    Effective Tax Rate (%) 27.57
    Particulars MAR 2026 (Values in Cr)
    Revenue 101.90
    Operating Expense 81.09
    Net Profit 18.09
    Net Profit Margin (%) 17.75
    Earnings Per Share (EPS) 15.50
    EBITDA 28.50
    Effective Tax Rate (%) 27.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 67.80
    Operating Expense 53.04
    Net Profit 13.05
    Net Profit Margin (%) 19.24
    Earnings Per Share (EPS) 11.35
    EBITDA 20.67
    Effective Tax Rate (%) 27.07
    Particulars MAR 2024 (Values in Cr)
    Revenue 44.65
    Operating Expense 37.05
    Net Profit 7.04
    Net Profit Margin (%) 15.76
    Earnings Per Share (EPS) 6.22
    EBITDA 11.03
    Effective Tax Rate (%) 28.16
    Particulars MAR 2023 (Values in Cr)
    Revenue 31.69
    Operating Expense 26.27
    Net Profit 6.01
    Net Profit Margin (%) 18.96
    Earnings Per Share (EPS) 6.22
    EBITDA 7.40
    Effective Tax Rate (%) 8.52
    Particulars MAR 2022 (Values in Cr)
    Revenue 21.77
    Operating Expense 19.39
    Net Profit 3.95
    Net Profit Margin (%) 18.14
    Earnings Per Share (EPS) 4.93
    EBITDA 3.31
    Effective Tax Rate (%) -32.21
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 56.05
    ROE % 17.88
    ROCE % 18.69
    Total Debt to Total Equity 0.62
    EBITDA Margin 26.74
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 45.14
    ROE % 12.06
    ROCE % 14.99
    Total Debt to Total Equity 0.26
    EBITDA Margin 23.10
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 39.69
    ROE % 22.44
    ROCE % 22.09
    Total Debt to Total Equity 0.20
    EBITDA Margin 23.45
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 5.97
    ROE % 49.35
    ROCE % 29.65
    Total Debt to Total Equity 0.51
    EBITDA Margin 15.25
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 57.16
    ROE % 22.04
    ROCE % 27.61
    Total Debt to Total Equity 0.18
    EBITDA Margin 30.69
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 45.81
    ROE % 14.32
    ROCE % 19.09
    Total Debt to Total Equity 0.10
    EBITDA Margin 24.82
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 39.68
    ROE % 22.41
    ROCE % 23.66
    Total Debt to Total Equity 0.12
    EBITDA Margin 23.41
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 5.97
    ROE % 60.77
    ROCE % 31.04
    Total Debt to Total Equity 1.62
    EBITDA Margin 15.25
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -0.94
    ROE % 63.00
    ROCE % 19.24
    Total Debt to Total Equity 0.00
    EBITDA Margin 14.66
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.46
    Total Assets 156.00
    Total Liabilities 156.00
    Total Equity 69.64
    Share Outstanding 1
    Price to Book Ratio 4.50
    Return on Assets (%) 7.53
    Return on Capital (%) 9.5
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.65
    Total Assets 87.07
    Total Liabilities 87.07
    Total Equity 53.95
    Share Outstanding 1
    Price to Book Ratio 3.58
    Return on Assets (%) 7.28
    Return on Capital (%) 8.77
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 13.77
    Total Assets 62.57
    Total Liabilities 62.57
    Total Equity 47.10
    Share Outstanding 1
    Price to Book Ratio 4.01
    Return on Assets (%) 9.61
    Return on Capital (%) 10.98
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.15
    Total Assets 13.83
    Total Liabilities 13.83
    Total Equity 4.77
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 28.53
    Return on Capital (%) 54.61
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.11
    Total Assets 97.79
    Total Liabilities 97.79
    Total Equity 65.72
    Share Outstanding 1
    Price to Book Ratio 4.50
    Return on Assets (%) 13.34
    Return on Capital (%) 16.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.00
    Total Assets 73.23
    Total Liabilities 73.23
    Total Equity 52.67
    Share Outstanding 1
    Price to Book Ratio 3.58
    Return on Assets (%) 9.61
    Return on Capital (%) 11.96
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 13.76
    Total Assets 56.49
    Total Liabilities 56.49
    Total Equity 45.63
    Share Outstanding 1
    Price to Book Ratio 4.01
    Return on Assets (%) 10.64
    Return on Capital (%) 12.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 13.82
    Total Liabilities 13.82
    Total Equity 4.77
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 28.55
    Return on Capital (%) 54.61
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 11.44
    Total Liabilities 11.44
    Total Equity -0.47
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.52
    Return on Capital (%) 15.59
    Particulars MAR 2025 (Values in Cr)
    Net Income 13.61
    Cash from Operations -4.35
    Cash from Investing -13.82
    Cash from Financing 19.76
    Net change in Cash -4.30
    Free Cash Flow 6.74
    Particulars MAR 2024 (Values in Cr)
    Net Income 8.69
    Cash from Operations 5.87
    Cash from Investing -20.36
    Cash from Financing 11.00
    Net change in Cash -7.13
    Free Cash Flow 23.76
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.58
    Cash from Operations -17.85
    Cash from Investing -9.68
    Cash from Financing 42.28
    Net change in Cash 13.59
    Free Cash Flow -10.93
    Particulars MAR 2022 (Values in Cr)
    Net Income 2.98
    Cash from Operations -0.41
    Cash from Investing -0.44
    Cash from Financing 0.80
    Net change in Cash 0.14
    Free Cash Flow 0.04
    Particulars MAR 2025 (Values in Cr)
    Net Income 17.90
    Cash from Operations 0.74
    Cash from Investing -7.87
    Cash from Financing 7.47
    Net change in Cash -3.89
    Free Cash Flow 5.96
    Particulars MAR 2024 (Values in Cr)
    Net Income 9.79
    Cash from Operations 3.27
    Cash from Investing -11.00
    Cash from Financing 2.35
    Net change in Cash -7.75
    Free Cash Flow 12.35
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.57
    Cash from Operations -16.03
    Cash from Investing -5.56
    Cash from Financing 35.80
    Net change in Cash 13.63
    Free Cash Flow -13.76
    Particulars MAR 2022 (Values in Cr)
    Net Income 2.98
    Cash from Operations -0.42
    Cash from Investing -0.49
    Cash from Financing 0.80
    Net change in Cash 0.11
    Free Cash Flow 0.03
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.85
    Cash from Operations 1.48
    Cash from Investing -0.55
    Cash from Financing -0.95
    Net change in Cash -0.03
    Free Cash Flow 2.04
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 12.90 1.50 238.25 23.12 38.85
    BLISS GVS PHARMA LTD 503.85 40.50 4.47 5343.64 118.35 552.90
    CIPLA LTD 1429.45 30.34 3.35 115477.45 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 459.95 20.29 3.32 1353.68 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 21.74 4.00 238.25 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.05 23.94 4.17 1543.97 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8092.00 105.68 23.17 20230.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 503.85 54.47 4.62 5343.64 118.35 552.90

    Trident Lifeline Limited shareholding pattern

    Holding
    31.89%
    62.58%
    5.25%
    0.26%
    6.93%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Trident Lifeline Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    259.75 -0.44 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 260.10
    • 26 Days 257.30
    • 10 Days 260.10
    • 50 Days 256.00
    • 12 Days 259.90
    • 100 Days 259.70
    • 20 Days 258.30
    • 200 Days 266.10
    259.97 PIVOT
    First Support 256.03 First Resistance 264.83 Second Support 251.17 Second Resistance 268.77 Third Support 247.23 Third Resistance 273.63
    RSI 53.89 ADX 33.50 MACD 2.53 Williams % R -61.61 Commodity Channel Index (CCI) 13.32
    Date 2026-07-16 Week 24500.00 Same Day 28800.00 Month 24436.00
    1 Year -0.26 3 Year 0.32
    Over 1 Month
    5.86% down
    Over 1 Year
    -3.37% down
    Over 3 Months
    4.56% down
    Over 3 Years
    20.26% down
    Over 6 Months
    -14.94% down
    Over 5 Years
    0.00% down

    Trident Lifeline Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Trident Lifeline Ltd?

    Answer Field

    Trident Lifeline Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 259.75 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Trident Lifeline Ltd Share?

    Answer Field

    The market cap of Trident Lifeline Ltd for NSE ₹ 0.00 & for BSE ₹ 310.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Trident Lifeline Ltd?

    Answer Field

    The 52 Week High and Low of Trident Lifeline Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 328.00 and ₹ 229.95.

    What is 1 year return for Trident Lifeline Ltd?

    Answer Field

    The 1 year returns on the stock has been -3.37%.

    What is the P/E Ratio of Trident Lifeline Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Trident Lifeline Ltd share is 17.21.

    What is the PB ratio of Trident Lifeline Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Trident Lifeline Ltd share is 83.03.

    How to Buy Trident Lifeline Ltd Share?

    Answer Field

    You can trade in Trident Lifeline Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Trident Lifeline Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Trident Lifeline Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Trident Lifeline Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |